AL

Alector

- NASDAQ:ALEC
Last Updated 2024-04-23

LinkedIn Profile

Access Alector historical Linkedin company profile data on number of followers, employee headcount and more

Rows

Open dataset
Ticker Symbol Entity Name As Of Date Company Name Followers Employees on Linkedin Link Industry Date Added Date Updated Description Website Specialities Logo HQ.Street HQ.City HQ.State HQ.Country HQ.Postal Headcount change in past 24 months Company Name Sector Industry
nasdaq:alec 12954251 Apr 21st, 2024 12:00AM Alector 16K 268.00 Open Apr 20th, 2024 10:48PM Apr 20th, 2024 10:48PM We have always walked our own path, at Alector. That’s what led us to the bold thinking and fresh, new approach of empowering the body’s immune system to fight disease. Join us in our mission to eliminate neurodegeneration and cancer through immuno-neurology and immuno-oncology. We are developing a broad portfolio of programs, currently in various stages of clinical trials. Alector is based in South San Francisco, CA. We were founded in 2013 by thought leaders in biotechnology, neuroscience, and antibody drug discovery. Open Biotechnology, Neurodegenerative disease, Neurodegeneration, and Immuno-neurology Open 131 Oyster Point Blvd South San Francisco California US 94080 Alector
nasdaq:alec 12954251 Apr 20th, 2024 12:00AM Alector 16K 268.00 Open Apr 19th, 2024 10:38PM Apr 20th, 2024 04:31PM We have always walked our own path, at Alector. That’s what led us to the bold thinking and fresh, new approach of empowering the body’s immune system to fight disease. Join us in our mission to eliminate neurodegeneration and cancer through immuno-neurology and immuno-oncology. We are developing a broad portfolio of programs, currently in various stages of clinical trials. Alector is based in South San Francisco, CA. We were founded in 2013 by thought leaders in biotechnology, neuroscience, and antibody drug discovery. Open Biotechnology, Neurodegenerative disease, Neurodegeneration, and Immuno-neurology Open 131 Oyster Point Blvd South San Francisco California US 94080 Alector
nasdaq:alec 12954251 Apr 19th, 2024 12:00AM Alector 16K 268.00 Open Apr 18th, 2024 10:47PM Apr 18th, 2024 10:47PM We have always walked our own path, at Alector. That’s what led us to the bold thinking and fresh, new approach of empowering the body’s immune system to fight disease. Join us in our mission to eliminate neurodegeneration and cancer through immuno-neurology and immuno-oncology. We are developing a broad portfolio of programs, currently in various stages of clinical trials. Alector is based in South San Francisco, CA. We were founded in 2013 by thought leaders in biotechnology, neuroscience, and antibody drug discovery. Open Biotechnology, Neurodegenerative disease, Neurodegeneration, and Immuno-neurology Open 131 Oyster Point Blvd South San Francisco California US 94080 Alector
nasdaq:alec 12954251 Apr 18th, 2024 12:00AM Alector 16K 268.00 Open Apr 17th, 2024 10:48PM Apr 18th, 2024 05:50PM We have always walked our own path, at Alector. That’s what led us to the bold thinking and fresh, new approach of empowering the body’s immune system to fight disease. Join us in our mission to eliminate neurodegeneration and cancer through immuno-neurology and immuno-oncology. We are developing a broad portfolio of programs, currently in various stages of clinical trials. Alector is based in South San Francisco, CA. We were founded in 2013 by thought leaders in biotechnology, neuroscience, and antibody drug discovery. Open Biotechnology, Neurodegenerative disease, Neurodegeneration, and Immuno-neurology Open 131 Oyster Point Blvd South San Francisco California US 94080 Alector
nasdaq:alec 12954251 Apr 17th, 2024 12:00AM Alector 16K 266.00 Open Apr 16th, 2024 10:36PM Apr 17th, 2024 02:14PM We have always walked our own path, at Alector. That’s what led us to the bold thinking and fresh, new approach of empowering the body’s immune system to fight disease. Join us in our mission to eliminate neurodegeneration and cancer through immuno-neurology and immuno-oncology. We are developing a broad portfolio of programs, currently in various stages of clinical trials. Alector is based in South San Francisco, CA. We were founded in 2013 by thought leaders in biotechnology, neuroscience, and antibody drug discovery. Open Biotechnology, Neurodegenerative disease, Neurodegeneration, and Immuno-neurology Open 131 Oyster Point Blvd South San Francisco California US 94080 Alector
nasdaq:alec 12954251 Apr 16th, 2024 12:00AM Alector 16K 266.00 Open Apr 15th, 2024 10:35PM Apr 16th, 2024 10:30AM We have always walked our own path, at Alector. That’s what led us to the bold thinking and fresh, new approach of empowering the body’s immune system to fight disease. Join us in our mission to eliminate neurodegeneration and cancer through immuno-neurology and immuno-oncology. We are developing a broad portfolio of programs, currently in various stages of clinical trials. Alector is based in South San Francisco, CA. We were founded in 2013 by thought leaders in biotechnology, neuroscience, and antibody drug discovery. Open Biotechnology, Neurodegenerative disease, Neurodegeneration, and Immuno-neurology Open 131 Oyster Point Blvd South San Francisco California US 94080 Alector
nasdaq:alec 12954251 Apr 15th, 2024 12:00AM Alector 16K 266.00 Open Apr 14th, 2024 10:38PM Apr 15th, 2024 04:11PM We have always walked our own path, at Alector. That’s what led us to the bold thinking and fresh, new approach of empowering the body’s immune system to fight disease. Join us in our mission to eliminate neurodegeneration and cancer through immuno-neurology and immuno-oncology. We are developing a broad portfolio of programs, currently in various stages of clinical trials. Alector is based in South San Francisco, CA. We were founded in 2013 by thought leaders in biotechnology, neuroscience, and antibody drug discovery. Open Biotechnology, Neurodegenerative disease, Neurodegeneration, and Immuno-neurology Open 131 Oyster Point Blvd South San Francisco California US 94080 Alector
nasdaq:alec 12954251 Apr 14th, 2024 12:00AM Alector 16K 264.00 Open Apr 13th, 2024 10:32PM Apr 14th, 2024 10:31AM We have always walked our own path, at Alector. That’s what led us to the bold thinking and fresh, new approach of empowering the body’s immune system to fight disease. Join us in our mission to eliminate neurodegeneration and cancer through immuno-neurology and immuno-oncology. We are developing a broad portfolio of programs, currently in various stages of clinical trials. Alector is based in South San Francisco, CA. We were founded in 2013 by thought leaders in biotechnology, neuroscience, and antibody drug discovery. Open Biotechnology, Neurodegenerative disease, Neurodegeneration, and Immuno-neurology Open 131 Oyster Point Blvd South San Francisco California US 94080 Alector
nasdaq:alec 12954251 Apr 13th, 2024 12:00AM Alector 16K 264.00 Open Apr 12th, 2024 10:22PM Apr 13th, 2024 10:59AM We have always walked our own path, at Alector. That’s what led us to the bold thinking and fresh, new approach of empowering the body’s immune system to fight disease. Join us in our mission to eliminate neurodegeneration and cancer through immuno-neurology and immuno-oncology. We are developing a broad portfolio of programs, currently in various stages of clinical trials. Alector is based in South San Francisco, CA. We were founded in 2013 by thought leaders in biotechnology, neuroscience, and antibody drug discovery. Open Biotechnology, Neurodegenerative disease, Neurodegeneration, and Immuno-neurology Open 131 Oyster Point Blvd South San Francisco California US 94080 Alector
nasdaq:alec 12954251 Apr 12th, 2024 12:00AM Alector 16K 264.00 Open Apr 11th, 2024 10:26PM Apr 12th, 2024 07:54AM We have always walked our own path, at Alector. That’s what led us to the bold thinking and fresh, new approach of empowering the body’s immune system to fight disease. Join us in our mission to eliminate neurodegeneration and cancer through immuno-neurology and immuno-oncology. We are developing a broad portfolio of programs, currently in various stages of clinical trials. Alector is based in South San Francisco, CA. We were founded in 2013 by thought leaders in biotechnology, neuroscience, and antibody drug discovery. Open Biotechnology, Neurodegenerative disease, Neurodegeneration, and Immuno-neurology Open 131 Oyster Point Blvd South San Francisco California US 94080 Alector

Request a demo to view additional historical data, and much more.

Request Demo

Make fast
queries

No longer rely on engineers to access data; build and share queries with intuitive tools, and derive insights in real time.

Bookmark queries with your team

Save and share custom queries using a private bookmarking feature, accessible to your whole team.

Be first to know with alerts

Scan data points across millions of companies and receive emails when relevant metrics cross critical thresholds.

Visualize data for quick insights

Create custom keyword-based word clouds, charts, and advanced visualizations to quickly analyze the data.

Map competitor locations

Analyze competitor presence and growth over time by overlaying store locations with the Nearby Competitor feature.

Add widgets to your dashboards

Access existing maps, charts, word clouds, and other visualizations to understand your data quickly. Or build custom widgets to view data just the way you want it.